Supplementation of CD138-depleted lupus mouse serum with 300 ng/ml of mouse CD138 significantly increased B220intCD138+ plasma cell development in APRIL- and LPS-stimulated B cells compared with cells stimulated with CD138-depleted serum (Fig. 4C). The gene discussed is TNFSF13; the disease is systemic lupus erythematosus.